Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 151

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 18
Chunk 151
---
2027.                                                                                               
●   On June 30, 2025, 4,650,000 options were forfeited upon resignation of employees.                                                                                                                           
 (d) Terms and Conditions of Reserves 
   Options and warrants
   Option holders and warrant holders do not have the right to receive dividends and are not entitled to vote at a meeting of the Group’s shareholders. Options and warrants may be exercised at any time from the date they vest to the date of their expiration. Share options are exercisable into ordinary shares on a one for one basis on the date they are exercised. Options granted under the 2018 ADS Plan are exercisable into ADRs, being one option for one ADR, which equals 600 ordinary shares, on the date they are exercised.   Expired options are reclassified into accumulated losses. Options forfeited due to failure of a vesting condition result in a reversal of the accumulated expense through the statement of profit or loss and other comprehensive loss.    In Australia, there is not a set number of authorized shares, shares are not reserved for the exercise of options, and shares do not have a par value.   (e) Options and Warrants Issued after Reporting Date
   15,000,000 options were issued under the 2004 ASX Plan after reporting date.

12. ACCUMULATED DEFICIT DURING DEVELOPMENT STAGE
   
                                                                            Years Ended June 30,                               
-------------------------------------------------------------------------------------------------------------------------------
                                             2025                        2024                         2023                     
Balance at beginning of year                          214,161,131                  195,130,889                  181,884,388    
Net loss for the year                                  12,147,828                   19,123,464                   13,806,515    
Reclassify expired options from reserves                 (326,544   )                        -                     (560,014   )
Reclassify forfeited options from reserves                (93,735   )                  (93,222   )                        -    
Balance at end of year                                225,888,680                  214,161,131                  195,130,889    
F-29

ALTERITY THERAPEUTICS LIMITED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – in Australian dollars (unless otherwise noted)

13. LEASES
   
(i)   Amounts recognised in the statement of financial position
---------------------------------------------------------------
   The statement of financial position shows the following amounts relating to leases:   
                                               Years Ended June 30